Citius Oncology Inc.CTORNASDAQ
Loading
Research and development spending
3Y CAGR
+13.3%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $6.17M | -3.8% |
| 2025 | $6.42M | +30.3% |
| 2024 | $4.92M | +16.1% |
| 2023 | $4.24M | -38.1% |
| 2022 | $6.86M | - |